Tuesday, 11 April 2017

New Report Covers Global Orphan Drugs Market 2017-2021

Report Global Orphan Drugs Market 2017-2021 is a new market research publication announced by Reportstack. 
Report Outline: According to Orphan Drug Designation program of the US Food and Drug Administration (FDA), orphan diseases are defined as rare diseases that affects less than 2,00,000 Americans. The global orphan drugs market is expected to benefit from patent extensions like Orphan Drug Exclusivity (ODE), increasing focus of vendors on orphan drug products, and financial incentives provided by government in form of tax credits and waived FDA fees. For instance, the FDA grants a seven-year patent exclusivity to orphan drugs to treat a rare disease. Therefore, any other drug with the same indication cannot be approved by the FDA during these seven-years period. In addition, they also provide tax credits up to 50% of the total R&D cost after the drug receives the orphan drug designation. This credit can be used by the sponsor during the R&D phase of any drug irrespective of the drug designation. The orphan designated drugs are also exempted from paying the FDA fees. Thus, these financial incentives and grants for orphan drug attract many vendors to invest in developing drugs for rare diseases and make huge profits.
For detailed report with TOC, please click here ​Global Orphan Drugs Market 2017-2021
Market Growth: The global orphan drugs market to grow at a CAGR of 10.20% during the period 2017-2021.
Key vendors • AbbVie
• Celgene
• F. Hoffmann La Roche
• Novartis
Other prominent vendors • Amgen
• Actelion 
• Alexion Pharmaceuticals 
• Bayer
• Biogen
• Bristol-Myers Squibb
• Eli Lilly 
• Johnson & Johnson
• Novo Nordisk
• Pfizer
• Sanofi
• Shire 
• Teva pharmaceutical
Regions Covered:
• Americas
Companies Mentioned
AbbVie, Celgene, F. Hoffmann La Roche, Novartis, Amgen, Actelion, Alexion Pharmaceuticals, Bayer, Biogen, Bristol-Myers Squibb, Eli Lilly, Johnson & Johnson, Novo Nordisk, Pfizer, Sanofi, Shire, and Teva pharmaceutical.
Debora White
Manager - Marketing
Ph: +1-888-789-6604
Reportstack Market Research

No comments:

Post a Comment